Editorial: the impact of COVID on management of IBD flares-different care but similar outcomes

Affiliations

Editorial

John P Haydek et al. Aliment Pharmacol Ther. 2023 Jan.

. 2023 Jan;57(1):154-155.

doi: 10.1111/apt.17259.

¹ Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

No abstract available

Comment in

Editorial: the impact of COVID on the management of IBD flares: different care but similar outcomes-authors' reply.
Saifuddin A, Kent AJ, Mehta SJ, Sebastian S. Saifuddin A, et al. Aliment Pharmacol Ther. 2023 Jan;57(1):156-157. doi: 10.1111/apt.17293. Epub 2022 Dec 5. Aliment Pharmacol Ther. 2023. PMID: 36468219 Free PMC article.

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Saifuddin A, Kent AJ, Mehta SJ, Hicks LC, Gonzalez HA, Segal JP, Brookes MJ, Subramanian S, Bhala N, Conley TE, Patel KV; PREPARE-IBD Collaborators; Lamb CA, Walker GJ, Kennedy NA, Sebastian S. Saifuddin A, et al. Aliment Pharmacol Ther. 2022 Nov;56(10):1460-1474. doi: 10.1111/apt.17223. Epub 2022 Oct 5. Aliment Pharmacol Ther. 2022. PMID: 36196569 Free PMC article.

1. Whaley CM, Pera MF, Cantor J, Chang J, Velasco J, Hagg HK, et al. Changes in health services use among commercially insured US populations during the COVID-19 pandemic. JAMA Netw Open. 2020;3(11):e2024984.
1. Danese S, Cecconi M, Spinelli A. Management of IBD during the COVID-19 outbreak: resetting clinical priorities. Nat Rev Gastroenterol Hepatol. 2020;17(5):253-5.
1. Saifuddin A, Kent AJ, Mehta SJ, Hicks LC, Gonzalez HA, Segal JP, et al. Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study. Aliment Pharmacol Ther. 2022;56:1460-1474.